Or Yehuda · Seed–Late Stage · 14 people tracked
Find your way into Peregrine Ventures
908 people in our graph share verified history with the Peregrine Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Peregrine Ventures, described as Israel's first dedicated healthcare fund, invests in and supports life science and medical technology companies with the goal of improving patient quality of life. It combines deep industry knowledge with an embedded, synergetic strategy, helping portfolio companies with business, regulatory, and investment strategies. The firm backs companies from seed and early/mid-stage through advanced growth, supporting them in building business strategies, forming strategic alliances, recruiting teams, and bringing healthcare innovations to market. Its dedicated investment vehicles include early and mid-stage funds, the 'Incentive' Incubator, and Peregrine Growth, a fund for mature companies in their final financing rounds before an M&A or IPO.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 39 of 69 portfolio companiesHealthtech ×28Medical Devices ×26Biotech ×19AI & Machine Learning ×8Digital Health ×6Robotics ×5Hardware ×4Deep Tech ×3
HQs:Israel×11United States×5Germany×1United Kingdom×1Nigeria×1
Who they back
founder profiles across 11 portfolio companiesFounding team size:solo founder×22 founders×73 founders×2
Investments · 69 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 22023 · 32021 · 32020 · 12019 · 12012 · 112 dated
Edwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions.
BiotechHealthtechMedical DevicesIrvine, US
Donald E. Bobo, Jr.(Executive Officer)inScott B. Ullem(Executive Officer)inLarry L. Wood(Executive Officer)inHuimin Wang(Executive Officer)inCatherine M. Szyman(Executive Officer)Bernard J. Zovighian(Executive Officer)in
Co-investorsALIVE Israel HealthTech FundVersant Venture AIV Holdings
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
Co-investorsAccelmed PartnersAccess Venture PartnersAlphaDriveaMoonTargeted Technology Funds
Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies.
BiotechDeep TechHealthtechMedical Devices
Lana Volokh(Co-founder)Alex Tendler(Co-founder)Yevgeny Tendler(CSO)
Co-investorsIsrael Biotech Fund
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Chaim Lotan(Executive Officer, Director)Ronit Haviv(Executive Officer)David Lifschitz(Director)Ilan Shalom(Executive Officer)Leon Eting(Executive Officer)Itai Katsir(Executive Officer)
Co-investorsPix Vine CapitalPeregrine
Incentive Incubator is a seed-stage incubator in Israel that screens early-stage companies and provides support through a network of business, technology, and strategic experts.
Digital HealthHealthtechMedical DevicesOr Yehuda, IL
Co-investorsPix Vine Capital
Magneto Thrombectomy Solutions develops catheter-based thrombectomy devices that remove blood clots from the vascular system using a combination of large-bore aspiration and proprietary electric-field attraction technology.
HardwareHealthtechMedical DevicesOr Yehuda, IL
Co-investorsAlive VenturesImpact Ventures PSMLatin Leap
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms.
BiotechDeep TechMedical Devices
Co-investorsCancer FocusIsrael Biotech Fund
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investors20/20 HealthCare Partners LLCBosch VenturesNew Era Capital PartnersOrbiMedPitangoQuark Venture Inc.+2 more
Momentis Surgical develops the Anovo Surgical System, a robotic platform designed for minimally-invasive surgery using a transvaginal approach with articulated instruments.
FemTechHealthtechMedical DevicesRoboticsOr Yehuda
Dvir Cohen(Chief Executive Officer)inNataly Fellous(Vice President Finance)inSteven Nunes(Chief Commercial Officer)inHagai Berkovich(Chief Operations Officer)Noam Atar(Chief Financial Officer)in
BoardMorry Blumenfeld(Director)
Board seatLior ShahoryEyal Lifschitz· per SEC Form D
Co-investorsAccelmed Partners
Aleph Farms develops cultivated meat, growing beef steaks from cow cells using tissue engineering technology, and produced the world's first cultivated thin-cut and ribeye steaks.
BiotechClimate TechFoodTech
Neta Lavon(Co-founder & CTO)inShulamit Levenberg(Co-founder)inDidier Toubia(Co-founder & CEO)in
Co-investorsAlumni VenturesBasecamp FundBloom8Castor VenturesCockpit InnovationStray Dog Capital+3 more
BioProtect develops a balloon spacer device for brachytherapy procedures, used to create spacing during cancer radiation treatment.
BiotechHealthtechMedical Devices
Itay Barnea(Chief Executive Officer)inDerek Webster(Chief Commercial Officer)inLee Adler(Chief Operating Officer)inShahar Shaked(Chief Financial Officer)inDafna Carmi-Yinon(Chief Product and Clinical Officer)in
Co-investorsAlmeda VenturesTriventuresMVM Life Science PartnersOlympus Innovation VenturesXenia Venture Capital
Bluefin is an orderbook-based decentralized derivatives exchange built for both first-time users and professional traders.
Crypto & Web3Fintech
Ahmad Jawaid(Founder)in
Co-investorsAltonomyAmber GroupCompoundFBG CapitalHashedLedgerPrime+11 more
Bluefin provides security-first payment infrastructure, including technologies to protect payment card and sensitive data for retailers and enterprises.
CybersecurityEnterprise SoftwareFintech
Co-investorsBaleon CapitalCamden PartnersAqua SparkCPT CapitalMoreVCPICO Venture Partners
Bluewhite develops autonomous unmanned ground vehicle (UGV) technology and physical AI for defense, homeland security, and heavy industrial ground operations.
AI & Machine LearningDefense TechRobotics
Co-investorsEntrée CapitalInsight PartnersAlumni VenturesLIP Ventures
Bluewhite develops physical AI and autonomous technology for unmanned ground vehicles (UGVs), converting conventional ground operations into autonomous missions for use in defense, homeland security, and heavy industrial applications.
AI & Machine LearningDefense TechRobotics
Co-investorsLIP Ventures BoutiqueAlumni VenturesEntrée CapitalInsight PartnersLIP Ventures
BRAIN.Q Technologies develops brain-focused medical technology, applying AI and data science to advance treatments for stroke and other acute brain injuries.
AI & Machine LearningDigital HealthMedical Devices
Yotam Drechsler(Chief Executive Officer & Co-founder, Director)inEsther Shohami(Chief Scientific Officer & Co-founder)inAmir Salhuv(Chief Technology Officer)in
Co-investorsHanaco Venture CapitalIT-Farm CorporationMillhouseOurCrowd
Cardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery.
HardwareHealthtechMedical DevicesOr Yehuda, IL
Curesign is a medical device company developing a system that combines sensors with signal processing and big data tools to help oncologists tailor patient-specific cancer treatments.
BiotechHealthtechMedical Devices
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus.
BiotechHealthtechMedical Devices
Co-investorsAccelmed PartnersTal Ventures
A stealth-mode company developing a medical device focused on cardiac care.
HealthtechMedical Devices
EndoStream Medical develops the Nautilus intrasaccular device, a self-conforming scaffold used with coils to treat wide-necked brain aneurysms by maximizing neck coverage and promoting progressive occlusion.
HardwareHealthtechMedical DevicesCaesarea, IL
EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling.
AI & Machine LearningBiotechHealthtechMedical Devices
Eric J. Messika(CEO)inAharon Brodie(CTO)
Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
Boston, US
Evan Witt(Executive Officer, Director)Josh Tayloe(Executive Officer)
Co-investorsAccelmed PartnersTal Ventures
Focal MD, founded in 2022, supports and advances medical innovation through global strategic investments.
BiotechHealthtechMedical DevicesRobotics
Dr. Adrian Paz(Co-founder & CMO)Nadav Ben Da'at(Co-founder & CTO)Maoz Handelman(CEO)in
Hairstetics is a medical device company developing synthetic hair implants for treating hair loss, particularly in women.
HealthtechMedical DevicesWellness & Fitness
Insightec develops Exablate Neuro, an MRI-guided focused ultrasound platform that treats Essential Tremor and tremor-dominant Parkinson's Disease through an incision-free outpatient procedure.
HealthtechMedical DevicesTirat Carmel
Roni Karie(Vice President - Finance)Shirel Aroshase(Vice President - Human Resources)inEyal Zadicario(General Manager)inMenashe Frank(Vice President - Legal)inJun (Jim) Tao(Chief Operating Officer)inMaurice R. Ferre(Chairman and Chief Executive Officer)in
Co-investorsCatalio Capital Management, LPExigent CapitalGEOCJazzya InvestmentsKoch Disruptive TechnologiesKrillion Ventures+7 more
Ionara Bio is an Israeli biotech startup developing small molecules that block the TRPV2 channel to reduce inflammatory damage to heart muscle, aiming to treat heart failure.
Levation Pharma is a pharmaceutical company developing LEV-102, a topical oxymetazoline-based gel for treating acquired blepharoptosis (drooping upper eyelids).
BiotechMedical Devices
Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise.
BiotechDigital HealthHealthtechMedical Devices
Antoni Ribas, M.D., Ph.D.(Founder and Chairman of the Board)Sumant Ramachandra(Chief Executive Officer and Board Director)inJonathan Benjamin(Clinical Development Lead)
Co-investorsaMoonPontifax Venture Capital
Magnisity develops a robotic guidance platform for lung endoscopy that uses patented disposable deformation sensors to provide real-time shape and location navigation inside the body, combining diagnosis and treatment in a single procedure.
HealthtechMedical DevicesRobotics
Benny Greenburg(Co-Founder & CEO)inRon Barak(Co-Founder & CTO)in
mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.
B2B MarketplacesDigital HealthHealthtechLogistics & Supply Chain
Co-investors4DX VenturesBreyer CapitalOTVThe Raba PartnershipTimon CapitalJam Fund+3 more
Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery.
HardwareHealthtechMedical DevicesCaesarea, IL
Co-investorsAccelmed Partners
OncoRedox is a publicly listed holding company that manages its own assets and acquires, holds, and disposes of investments in companies in Germany and abroad, with a focus on minimally invasive blood tests for cancer detection.
BiotechHealthtechHeidelberg, DE
Co-investorsLongevity Venture Partners
Raziel develops a proprietary fat-dissolving injectable compound (RZL-012) for non-surgical, one-time focal fat reduction addressing both aesthetic and therapeutic needs, including submental (double-chin) fat and Dercum's disease.
BiotechHealthtechMedical DevicesHod Hasharon, IL
Alon Bloomenfeld(CEO & Founder)
Co-investorsPontifax Venture Capital
Restore Medical is a medical device company in the cardiology field, developing technology associated with interventional cardiology and cardiac research.
HealthtechMedical DevicesTel Aviv, IL
Jason Dunphy(Executive Officer, Director)Richard Mark O'Sullivan(Executive Officer, Director)
BoardShmuel Banai(MD, Professor of Cardiology)
BiotechLexington, US
Victoria M. Richon(Executive Officer, Director)in
BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)
Co-investorsAvego BioScience CapitalOUP (Osage University Partners)AbbVieNovartis Venture FundThe Column Group
Terrapeutics operates a drug discovery platform that screens natural compounds produced by soil microorganisms to find molecules targeting "undruggable" disease targets such as protein-protein interactions and transcription factors.
BiotechDeep Tech
Trojan Bio develops bispecific antibodies for cancer immunotherapy, using an AI-driven platform that pairs a cancer-targeting module with a viral immunity activation module to mark tumor cells as virally infected and recruit anti-viral immune responses.
AI & Machine LearningBiotechHealthtech
Co-investorsNFX
Validify offers an automated approach to computer system validation (CSV) and regulatory compliance, replacing manual validation processes.
AI & Machine LearningEnterprise SoftwareHealthtechSaaS
Wanda Fish develops cell-cultivated seafood, with a flagship cultivated toro bluefin tuna product grown using cell culture and biotechnology methods.
BiotechClimate TechFoodTech
Co-investorsAqua SparkMoreVCCPT CapitalPICO Venture Partners
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
BiotechHealthtechMedical Devices
Guy Yachin(Co-Founder & CEO)inDr. Michael Shtein(Co-Founder & CSO)Prof. Cullen Taniguchi(Co-Founder)
Co-investorsSIBF (Southern Israel Bridging Fund) VC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Althea MedicalAlumaArTack MedicalArtFixB-BalloonBioRefineCardio GardClearMarginConAir MedicalDairyXEledonEndomaticHeraCureKahrKansoLife TherapeuticsNeovascNextVivoNLTPotentia TherapeuticsSinuSafeSnipeSuperSpectraVisionsenseW Endoluminal RoboticsWanda
Exits · 4
2 IPOs · 2 acquisitionsEdwards LifesciencesNYSE: EWSmith+NephewNYSE: SNNB-Balloonacq. by NeovascVisionsenseacq. by Medtronic
Portfolio news
latest coverage across their companiesBluefin · finovate.com · Sep 14, 2026
Edwards Lifesciences · biospace.com · Sep 3, 2026
Ribon Therapeutics · geekwire.com · Aug 14, 2026
Aleph Farms · calcalistech.com · Jun 2, 2026
Bluewhite · agfundernews.com · May 28, 2026
Bluewhite · agfundernews.com · May 28, 2026
Cardiovalve · cfrjournal.com · Jan 3, 2026
Mpharma · billionaires.africa · Dec 22, 2025
Frequently asked questions
- How many investments has Peregrine Ventures made?
- Peregrine Ventures has 69 tracked investments, 4 of which have exited, including 1 dated in the last 24 months.
- What stage does Peregrine Ventures invest at?
- Peregrine Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Peregrine Ventures's typical check size?
- Peregrine Ventures typically writes checks of $500K – $3M.
- What sectors does Peregrine Ventures focus on?
- Peregrine Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Peregrine Ventures located?
- Peregrine Ventures is headquartered in Or Yehuda, IL.
- Who does Peregrine Ventures co-invest with?
- Peregrine Ventures most often shares deals with Accelmed Partners, aMoon, Pontifax Venture Capital, among 44 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInvestor Connect - 392 - Eyal Lifschitz of Peregrine Ventures
Hall Martin · Eyal Lifschitz
Images
Similar investors
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.
Bay City Capital is a venture capital firm founded in 1997 that has raised five venture funds totaling $1.3 billion in capital commitments and invested in more than 100 companies worldwide.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.
Clal Biotechnology Industries (TASE: CBI) is an Israeli life sciences investment firm listed on the Tel Aviv Stock Exchange, focused on identifying and developing ventures that create proprietary solutions for unmet medical needs.